Fractyl Health, Inc.

The momentum for this stock is not very good. Fractyl Health, Inc. is not a good value stock. Fractyl Health, Inc. is not a good growth stock. Fractyl Health, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Fractyl Health, Inc..

News

Fractyl Health participates in a conference call with Truist

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Fractyl Health to Participate in Upcoming September Investor Conferences

Globe Newswire BURLINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company ), a metabolic therapeutics company focused on pioneering new approaches that treat root...\n more…

Fractyl Health Second Quarter 2024 Earnings: US$0.36 loss per share (vs US$14.56 loss in 2Q 2023)

Simply Wall St Fractyl Health ( NASDAQ:GUTS ) Second Quarter 2024 Results Key Financial Results Net loss: US$17.2m (loss narrowed by...\n more…

Fractyl Health, Inc. (GUTS) Q2 2024 Earnings Call Transcript

Seeking Alpha: Transcripts Fractyl Health, Inc. (GUTS) Q2 2024 Earnings Call Transcript...\n more…

GUTS Stock Earnings: Fractyl Health Beats EPS for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nGUTS stock results show that Fractyl Health beat analyst estimates for earnings per share the second quarter of 2024.\nThe post GUTS...\n more…

Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates

Globe Newswire Updated clinical results from German Real-World Registry demonstrate potential for Revita to meaningfully sustain weight loss and lower blood sugar for at least one-year post-treatment in a...\n more…